Aurora Cannabis urges shareholders to reject Curaleaf hostile bid
Aurora Cannabis says Curaleaf’s hostile bid is inadequate, undervalues Aurora, and risks shareholder value and future upside.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.